Effect of fluid balance control in critically ill patients: Design of the stepped wedge trial POINCARE-2.

Nelly Agrinier, Alexandra Monnier, Laurent Argaud, Michel Bemer, Jean-Marc Virion, Camille Alleyrat, Claire Charpentier, Laurent Ziegler, Guillaume Louis, Cédric Bruel, Matthieu Jamme, Jean-Pierre Quenot, Julio Badie, Francis Schneider, Pierre-Edouard Bollaert

Journal: Contemporary clinical trials 2020;83():109-116

PMID: 31260794

Abstract

A high number of recent studies have shown that a positive fluid balance is independently associated with impaired prognosis in specific populations of patients hospitalized in intensive care unit (ICU): acute kidney injury, acute respiratory distress syndrome (ARDS), sepsis, high risk surgery. However, to date, there is no evidence that control of fluid overload reduces mortality in critically ill patients. The main objective is to assess the efficacy of a strategy limiting fluid overload on mortality in unselected critically ill patients hospitalized in ICU. We hypothesized that a strategy based on a weight-driven recommendation of restricted fluid intake, diuretics, and ultrafiltration initiated from 48 h up to 14 days after admission in critically ill patients would reduce all-cause mortality as compared to usual care. We use a stepped wedge cluster randomized controlled trial combined with a quasi-experimental (before-and-after) study. Patients under mechanical ventilation, admitted since >48 h and < 72 h in ICU, and with no discharge planned for the next 24 h are eligible. A total of 1440 patients are expected to be enrolled in 12 ICUs. Sociodemographic and clinical data are collected at inclusion, and outcomes are collected during the follow-up. Primary outcome is all-cause mortality at 60 days after admission. Secondary outcomes are patients weight differences between admission and day7 (or day 14), 28-day, in-hospital, and 1-year mortality, end-organ damages, and unintended harmful events. Analyses will be held in intention-to-treat. If POINCARE-2 strategy proves effective, then guidelines on fluid balance control might be extended to all critically ill patients. Trial registration: ClinicalTrials.govNCT02765009.

Copyright © 2019 Elsevier Inc. All rights reserved.

Address: CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, F-54000 Nancy, France; Université de Lorraine, APEMAC, F-54000 Nancy, France. Electronic address: [email protected].; CHRU Strasbourg, Nouvel Hôpital Civil, Service de Réanimation médicale, F-67000 Strasbourg, France.; Hospices civils de Lyon, Hôpital Edouard Herriot, Service de réanimation médicale, F-69000 Lyon, France.; CHR Metz-Thionville, Service de Réanimation polyvalente, F-57000 Thionville, France.; CHRU-Nancy, INSERM, Université de Lorraine, CIC, Epidémiologie Clinique, F-54000 Nancy, France.; CHRU-Nancy, Université de Lorraine, Service d'Anesthésie Réanimation chirurgicale, F-54000 Nancy, France.; CH Verdun, Service d'anesthésie réanimation, F-55000 Verdun, France.; CHR Metz-Thionville, Service de Réanimation polyvalente, F-57000 Metz, France.; Groupe hospitalier Paris Saint-Joseph, Service de réanimation polyvalente, F-75000 Paris, France.; CHI Poissy Saint-Germain, Service de Réanimation, F-78303 Poissy, France.; CHU Dijon-Bourgogne, Service de Médecine Intensive-Réanimation, F-21000 Dijon, France.; Hôpital Nord Franche-Comté, Service de Réanimation médicale, F-90015 Belfort, France.; CHU Strasbourg, Hôpital de Hautepierre, Service de Médecine Intensive Réanimation, INSERM U 1121, F-67000 Strasbourg, France.; Université de Lorraine, CHRU-Nancy, Service de Médecine Intensive Réanimation, F-54000 Nancy, France.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.